Market Highlights: Universal Technical Institute Inc (UTI) Ends on a Low Note at 14.99

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

The price of Universal Technical Institute Inc (NYSE: UTI) closed at $14.99 in the last session, down -0.20% from day before closing price of $15.02. In other words, the price has decreased by -$0.20 from its previous closing price. On the day, 0.4 million shares were traded. UTI stock price reached its highest trading level at $15.36 during the session, while it also had its lowest trading level at $14.99.

Ratios:

We take a closer look at UTI’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.68 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.71. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 1.39 whereas as Long-Term Debt/Eq ratio is at 1.28.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Northland Capital on January 10, 2024, initiated with a Outperform rating and assigned the stock a target price of $16.

On July 12, 2022, Rosenblatt started tracking the stock assigning a Buy rating and target price of $11.Rosenblatt initiated its Buy rating on July 12, 2022, with a $11 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 26 ’24 when Sanchez Loretta Lydia sold 8,719 shares for $15.07 per share. The transaction valued at 131,381 led to the insider holds 20,000 shares of the business.

Coliseum Capital Management, L sold 3,956,427 shares of UTI for $59,544,226 on Feb 15 ’24. The Director now owns 9,334,215 shares after completing the transaction at $15.05 per share. On Dec 14 ’23, another insider, Anderson Troy R, who serves as the EVP and CFO of the company, sold 7,173 shares for $10.94 each. As a result, the insider received 78,473 and left with 87,442 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UTI now has a Market Capitalization of 806484480 and an Enterprise Value of 1012757824. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 41.67, and their Forward P/E ratio for the next fiscal year is 16.33. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.78. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.18 while its Price-to-Book (P/B) ratio in mrq is 3.47. Its current Enterprise Value per Revenue stands at 1.484 whereas that against EBITDA is 15.314.

Stock Price History:

The Beta on a monthly basis for UTI is 1.23, which has changed by 1.4533551 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, UTI has reached a high of $17.09, while it has fallen to a 52-week low of $5.68. The 50-Day Moving Average of the stock is -0.36%, while the 200-Day Moving Average is calculated to be 27.59%.

Shares Statistics:

According to the various share statistics, UTI traded on average about 601.37K shares per day over the past 3-months and 852770 shares per day over the past 10 days. A total of 53.73M shares are outstanding, with a floating share count of 49.87M. Insiders hold about 7.20% of the company’s shares, while institutions hold 74.02% stake in the company. Shares short for UTI as of 1714435200 were 1272559 with a Short Ratio of 2.12, compared to 1711584000 on 1505905. Therefore, it implies a Short% of Shares Outstanding of 1272559 and a Short% of Float of 3.25.

Dividends & Splits

The stock’s 5-year Average Dividend Yield is 3.72.

Earnings Estimates

Universal Technical Institute Inc (UTI) is presently subject to a detailed evaluation by 5.0 analysts, each offering their unique perspectives on its market standing.On average, analysts expect EPS of $0.08 for the current quarter, with a high estimate of $0.11 and a low estimate of $0.05, while EPS last year was -$0.05. The consensus estimate for the next quarter is $0.31, with high estimates of $0.33 and low estimates of $0.29.

Analysts are recommending an EPS of between $0.73 and $0.68 for the fiscal current year, implying an average EPS of $0.7. EPS for the following year is $0.87, with 4.0 analysts recommending between $0.95 and $0.81.

Revenue Estimates

For the next quarter, 5 analysts are estimating revenue of $191.57M. There is a high estimate of $194.3M for the next quarter, whereas the lowest estimate is $189.5M.

A total of 5 analysts have provided revenue estimates for UTI’s current fiscal year. The highest revenue estimate was $724.8M, while the lowest revenue estimate was $714.07M, resulting in an average revenue estimate of $718.29M. In the same quarter a year ago, actual revenue was $607.41MBased on 5 analysts’ estimates, the company’s revenue will be $782.78M in the next fiscal year. The high estimate is $804.6M and the low estimate is $758.72M.

Most Popular

[the_ad id="945"]